Cancer Diagnosis Sarcoma vs. Carcinoma: Differences and Similarities By Lynne Eldridge, MD Lynne Eldridge, MD Facebook Lynne Eldrige, MD, is a lung cancer physician, patient advocate, and award-winning author of "Avoiding Cancer One Day at a Time." Learn about our editorial process Updated on March 03, 2023 Medically reviewed by Doru Paul, MD Medically reviewed by Doru Paul, MD Doru Paul, MD, is board-certified in internal medicine, medical oncology, and hematology. Learn about our Medical Expert Board Print Table of Contents View All Table of Contents Similarities Basic Differences Signs and Symptoms Causes and Risk Factors Diagnosis, Screening, and Staging Tumor Grade Behavior Treatment Options There are a number of differences between sarcomas and carcinomas, though individual cancers within each category can vary tremendously. Carcinomas account for the majority of cancers with only 1% of cancers in adults being sarcomas. In children, however, sarcomas account for over 15% of cancers, making research critical. Carcinomas arise out of epithelial cells that line the surface and organs of the body, whereas sarcomas arise from connective tissues such as bone, cartilage, fibrous tissue, blood vessels, and nerves. Learn about the similarities and differences with regard to subtypes, symptoms, causes, diagnosis, treatments, and prognosis. Similarities Between Sarcomas and Carcinomas There are many differences between sarcomas and carcinomas, so it is helpful to begin by talking about the similarities. Some of these include: Both are cancer (malignant): There are a number of differences between malignant tumors and benign tumors, with a major difference being that malignant tumors can spread to distant regions of the body.Both can be relatively treatable or life-threatening: Low-grade sarcomas and some carcinomas such as basal cell carcinoma of the skin can be very treatable. Likewise, some sarcomas as well as some carcinomas (for example, pancreatic cancer) are very challenging to treat with saddening five-year survival rates.Both can occur at any age: While sarcomas are more commonly found in young people, both sarcomas and carcinomas may be diagnosed at any age.With both, the cause is often unknown: While certain genetic syndromes as well as exposures may be associated with both sarcomas and carcinomas, the exact cause of either type of cancer is often unknown.Both can be difficult to diagnose: Both sarcomas and carcinomas may be misdiagnosed at first.Both require people to be their own advocates: With both sarcomas and uncommon types of carcinomas, finding physicians who specialize in these rare or uncommon cancers may improve outcomes. Cancer Cells vs. Normal Cells: How Are They Different? Basic Differences There are also many differences between sarcomas and carcinomas. Carcinomas are much more common, accounting for 85% to 90% of cancers. Sarcomas, in contrast, represent slightly less than 1% of cancer types. (The other types of cancer include leukemias, lymphomas, and myelomas, although some cancers may have characteristics of more than one type, for example, carcinosarcomas.) Carcinomas tend to be more common in people over the age of 50, but can occur in young adults and children. Sarcomas may occur at any age, but are often diagnosed in children and young adults. Roughly 15% of cancers diagnosed in people less than 20 years of age are sarcomas. Origin/Cell Types During in utero development of the embryo (embryogenesis), differentiation (the process of different tissues being formed) begins with the formation of three germ layers. These include the: Ectoderm: The layer which eventually becomes the skin and mucous membranes of the nose, the lining of organs, and nerve tissueMesoderm: The layer which differentiates into connective tissue, lining of the lungs (pleura), heart (pericardium), and abdomen (peritoneum), and blood cellsEndoderm: The layer which forms the lining of the gastrointestinal tract, the lower respiratory tract, and more Sarcomas begin in cells known as mesenchymal cells, often derived from the mesoderm, whereas carcinomas begin in epithelial cells; cells derived from the ectoderm and endoderm and that line the inside and outside surfaces of the body. That said, there are some exceptions. For example, the epithelial cells on the inner surface of the uterus (endometrium), bladder, and vagina are derived from the mesoderm. Tissues Carcinomas arise in tissues that line the body cavities or the skin, for example, the airways of the lung and the milk ducts of the breast. Sarcomas arise in tissues referred to as connective tissue, including bone, cartilage, fat, nerves, muscles, ligaments, tendons, nerves, and more. Sarcomas are often separated into two main categories; bone sarcomas that include tumors of bone, cartilage, and bone marrow, and soft tissue sarcomas. Types and Subtypes of Carcinomas Carcinomas are named according to the tissue in which they arise as well as the type of cells. Adenocarcinoma: Adenomatous cells are glandular cells that secrete substances such as mucus Squamous cell carcinoma: Squamous cells are flat cells found on surfaces, such as the outer layer of skin and lining of the upper esophagus Basal cell carcinoma: Basal cells are found in the deepest layer of skin Transitional cell carcinoma: Transitional cells are cells that stretch and are found in areas such as the bladder Different subtypes may occur in different regions of the same organ, for example, non-small cell lung cancers may be squamous cell carcinomas of the lung or lung adenocarcinomas. Similarly, esophageal cancers may arise in squamous cells (squamous cell carcinomas) or glandular cells (adenocarcinomas). Common carcinomas include lung adenocarcinoma, colon adenocarcinoma, squamous cell carcinomas of the head and neck, bladder cancer (most often a transitional cell carcinoma), and basal cell carcinomas of the skin. Tissue Types and Subtypes of Sarcomas Unlike carcinomas, there are over 50 different subtypes of sarcomas. Examples of sarcoma based on tissue type include: Bone (osteosarcoma or osteogenic sarcoma) Fat (adipose tissue): liposarcoma Cartilage: chondrosarcoma Smooth muscle (such as in the uterus): leiomyosarcoma Skeletal muscle: rhabdomyosarcoma Fibrous tissue: fibrosarcoma Joint lining: synovial sarcoma Blood vessels: angiosarcoma, when lymph vessels are involved, these tumors are referred to as lymphoangiosarcomas Mesothelium: mesothelioma (these tumors may involve the pleura (mesothelium around the lungs), pericardium (membranes around the heart) or peritoneum (membranes around the abdomen). Nerves: neuroblastoma, medulloblastoma Cells surrounding nerves: neurofibrosarcomas, malignant Schwammomas Connective tissue in the brain: glioma, astrocytoma Digestive tract: gastrointestinal stromal tumors (GISTs) Primitive embryonic tissue: myxosarcoma Combination of cell types: undifferentiated pleomorphic sarcoma (previously called malignant fibrous histiocytoma) The most common sarcomas in childhood are rhabdomyosarcomas. In adults, the most common sarcomas are soft tissue sarcomas, including undifferentiated pleomorphic sarcoma, liposarcomas, and leiomyosarcomas. Overlap Between Sarcomas and Carcinomas The region of the body does not always distinguish sarcomas and carcinomas. For example, breast sarcomas (that account for less than 1% of breast cancers) arise in the connective tissue of the breasts rather than milk ducts or lobules. Most "colon cancers" are adenocarcinomas, but 1% to 2% of tumors in this region are leiomyosarcomas of the colon and rectum. Some tumors may have characteristics of both carcinomas and sarcomas and may be referred to as carcinosarcomas or sarcomatoid carcinomas. Cancer Terminology: Oma vs. Sarcoma Etc. Most of the time (but not always), the description of a tumor differentiates benign connective tissue tumors from malignant sarcomas. For example, a lipoma is a benign tumor of fat (adipose tissue), and a liposarcoma is a cancerous tumor of the tissue. A hemangioma is a benign tumor of blood vessels, whereas a hemangiosarcoma is a malignant tumor. There are exceptions in this classification as well. For example, a chordoma (tumor of the nuchal cord) is malignant. A glioma is a cancer (not benign tumor) of glial cells in the brain. Sometimes, the word malignant is used to distinguish benign and malignant tumors. For example, a meningioma refers to a benign tumor of the meninges (membranes lining the brain), whereas a cancerous tumor is referred to as malignant meningioma. Signs and Symptoms Carcinomas may declare themselves with a number of symptoms often related to the organ in which they arise. For example, lung cancer may present with a cough or shortness of breath, breast cancer may present with a breast lump, and pancreatic cancer may present with jaundice, though not usually until the disease is very advanced. Sarcomas can likewise present with different symptoms. Sarcomas that arise in the arms and legs often present as a mass that can be painful or painless. When pain is present, it is often worst at night. Sarcomas in bone (osteosarcomas) may present with bone pain or swelling over or near bones. In some cases, the condition is only diagnosed after a fracture occurs (pathologic fracture) through an area of bone that has been weakened by the tumor. With Ewing sarcoma, the swelling or lump often feels warm and may be associated with a fever. Sarcomas of the digestive tract (GI stromal tumors) may have symptoms similar to colon carcinoma such as blood in the stool, abdominal pain, or weight loss. Causes and Risk Factors The major risk factors for carcinomas are fairly well known, and include lifestyle factors (such as smoking, obesity, and sedentary behavior), radiation (including ultraviolet radiation), genetics, age, viral infections, and environmental exposures among others. In most cases with sarcomas, identifiable risk factors aren't present, and these tumors have not been found to be associated with smoking, obesity, diet, or lack of exercise. Risk factors for sarcomas may include: Radiation, such as radiation therapy, as well as some types of chemotherapy drugs (Cancers that develop due to the carcinogenic properties of prior cancer treatments are referred to as secondary cancers) Environmental exposures, including exposure to vinyl chloride, some herbicides, arsenic, and thorium dioxide HIV infection (a risk factor for Kaposi's sarcoma) Uncommon genetic syndromes such as neurofibromatosis, Li-Fraumeni syndrome, Werner syndrome, Gorlin syndrome, Costello syndrome, Bloom syndrome, Diamond-Blackfan syndrome, Noonan syndrome, Beckwith-Wiedermann syndrome, tuberous sclerosis, familial adenomatous polyposis Some sarcomas are associated with certain developmental time periods. For example, osteosarcomas are most common during bone growth between the ages of 10 and 20. With some sarcomas, risk factors have been identified and studied to a greater extent. For example, angiosarcoma of the breast has been associated with chronic lymphedema, radiation therapy for breast cancer, and a particular type of breast implants (that have now been withdrawn from the market). Mesothelioma is strongly associated with asbestos exposure. Rhabdomyosarcomas in children have also been associated with parental use of cocaine and marijuana. Few risk factors have been identified at this time for Ewing sarcoma, though these cancers appear to be more common among children who have had hernias. Diagnosis, Screening, and Staging The diagnostic process for sarcomas can be similar to carcinomas, and often begins with scans (such as a CT scan, MRI, bone scan, or PET scan), or in the case of digestive tract sarcomas, endoscopy. Similarly, a biopsy is needed to determine the type of cancer as well as the tumor grade (the aggressiveness of the cancer). Special stains may likewise be helpful. As with carcinomas, DNA testing (such as next-generation sequencing) is often helpful, but in the case of some sarcomas, RNA testing may be helpful as well. Genomic Testing for Carcinomas and Sarcomas Screening Unlike carcinomas such as breast cancer, lung cancer, and colon cancer, general screening tests are not currently available for sarcomas. Precancerous Phase vs. No Precancerous Phase With carcinomas, tumors can sometimes be detected before they are invasive (before they extend through something known as the basement membrane). These precancerous tumors are non-invasive and are referred to as carcinoma in situ or stage 0 cancer. For example, when stage 0 lung cancer is detected it may be treated before it has the opportunity to become invasive and potentially spread. In contrast, once a sarcoma is detected it is considered invasive. Staging There are also differences in staging methods due to the way in which carcinomas and sarcomas often spread. TNM staging with carcinomas looks at the size of a tumor (T), the presence or absence of tumor cells in lymph nodes (N), and the presence or absence of metastases. Carcinomas often spread first to lymph nodes, but this spread does not mean the carcinoma is metastastic. In fact, cancers such as stage 2 breast cancer may have spread to lymph nodes. Sarcomas usually spread via the bloodstream and much less often through the lymphatic system. For this reason, they are less likely to spread to lymph nodes, and when they do spread, are more likely to be found in another organ (such as the lungs). With staging of sarcomas, the tumor grade (aggressiveness of the cancer cells) is often more important. Lung Cancer TNM Staging Tumor Grade The behavior, treatment, and prognosis of sarcomas relate strongly to their tumor grade. Behavior Carcinomas and sarcomas can behave differently with how they grow and spread. Carcinomas tend to grow and invade nearby structures, and in fact, the derivation of the word cancer from the word "crab" refers to these fingerlike projections or spicules that invade other structures. These cancers can spread locally in this way, via the lymphatic system, the bloodstream, and in the case of lung cancer, through the airways (aerogenous metastases). Sarcomas often grow as more of a ball, pushing structures (such as nerves and blood vessels) out of their way rather than invading them. They spread primarily through the bloodstream, with the most common site of metastasis being the lungs. Treatment Options In general, sarcomas can be more challenging to treat both in having fewer options available, and due to the fact that surgery (such as amputations in children) can be very disfiguring. Newer treatments, however, are becoming available such as targeted therapies and limb-sparing surgery. Surgery Surgery is often the treatment of choice for sarcomas as well as early stage carcinomas. Newer limb-sparing techniques have been developed for children with sarcomas, and the use of targeted therapies (see below) has in some cases reduced the size of a sarcoma prior to surgery so that much less extensive surgery is possible. Radiation Therapy Radiation therapy is commonly used with both sarcomas and carcinomas. Chemotherapy Many sarcomas are less responsive to chemotherapy than carcinomas, but this varies, for example, rhabdomyosarcomas in children tend to respond well to chemotherapy. Targeted Therapy Targeted therapies, or treatments that target specific abnormalities in the growth of cancer cells, have made a significant difference in the treatment of carcinomas such as some breast cancers and non-small cell lung cancers. These drugs are making a difference in the treatment of some sarcomas as well. In 2018, the drug Vitrakvi (larotrectinib) was approved for cancers, regardless of type, that harbor a NTRK fusion gene. This includes roughly 1% of solid tumors (such as colon cancer, lung cancer, and breast cancer) but up to 60% of some sarcomas, such as infantile fibrosarcoma. As a treatment that can target both sarcomas and carcinomas, Vitrakvi is an example of precision medicine, and how cancer treatment is changing such that it focuses on genetic abnormalities in the cancer cells rather than the cell type or tissue of origin. Immunotherapy Immunotherapy drugs such as checkpoint inhibitors have been a paradigm change in the treatment of some cancers, with sometimes drastic improvement in even very advanced metastatic carcinomas. Fortunately, these treatments are now being investigated for use in metastatic sarcoma as well, particularly undifferentiated pleomorphic sarcoma, myxofibrosarcoma, leiomyosarcoma, and angiosarcoma. Prognosis The prognosis of sarcomas and carcinomas depends strongly on the particular type of cancer, the aggressiveness of the tumor, age at diagnosis, and the stage at which they are diagnosed. For soft tissue sarcomas, the 5-year survival rate for localized tumors is 81%, which drops to 16% for metastatic tumors. Summary of Differences Sarcomas vs. Carcinomas Cancer Type Sarcomas Carcinomas Cell type of origin Mesenchymal cells Epithelial cells Tissue types Connective tissue Most organs Subtypes Over 50 4 Common types Children: rhadomyosarcoma, Ewing tumorAdults: Liposarcoma, leiomyosarcoma, undifferentiated pleomorphic sarcoma, GOST Lung cancer, breast cancer, colon cancer, prostate cancer Microscopic appearance Cells arranged individually Cells arranged in groups Genomic testing DNA and RNA testing DNA testing Staging Size and tumor grade most important Size and lymph node involvement most important Behavior Grow as a ball, often rapidlyPushes nearby structures out of the way Grow via fingerlike projections, often slowerInvades nearby structures such as nerves and blood vessels Vascularity More Less Causes/risk factors Often unknownMedical radiation, genetic syndromes, some exposures Lifestyle factors: smoking, diet, exerciseRadiation, environmental exposuresGeneticsMore Precancerous phase No Yes Spread (metastases) Spread via the bloodstream, lung most common Spread via the lymphatic system and bloodstream Prognosis/survival Dependent on many factors Dependent on many factors A Word From Verywell There are a number of important differences between sarcomas and carcinomas, including treatment. That said, as our understanding of cancer improves and treatment focuses on treatment underlying genetic anomalies in the cancer cells, the distinction between the two categories of cancer types may become less important. 2 Sources Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. Burningham, Z., Hashnibe, M., Spector, L., and J. Schiffman. The Epidemiology of Sarcoma. Clinical Sarcoma Research. American Society of Clinical Oncology. Cancer.Net. Sarcoma, Soft Tissue: Statistics. Additional Reading American Society of Clinical Oncology. Cancer.Net. Sarcoma, Soft Tissue: Statistics. National Cancer Institute. SEER Training Modules. Categories of Cancer. By Lynne Eldridge, MD Lynne Eldrige, MD, is a lung cancer physician, patient advocate, and award-winning author of "Avoiding Cancer One Day at a Time." See Our Editorial Process Meet Our Medical Expert Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookies Settings Accept All Cookies